Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Chambers

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|May 1, 1994
Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocolS K Chambers, L Lamb, E I Kohorn, et al.
Obstetrics and Gynecology|February 1, 1985
Immediate versus delayed hysterectomy for endometrial carcinoma: surgical morbidity and hospital stayJ T Chambers, D S Kapp, R Lawrence, et al.
Obstetrics and Gynecology|September 1, 1988
Evaluation of the role of second-look surgery in ovarian cancerS K Chambers, J T Chambers, E I Kohorn, et al.
American Journal of Clinical Pathology|September 1, 1990
Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlationsM L Carcangiu, J T Chambers, I M Voynick, et al.
Obstetrics and Gynecology|January 1, 1987
Uterine papillary serous carcinomaJ T Chambers, M Merino, E I Kohorn, et al.
Gynecologic Oncology|March 1, 1996
Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamideJ T Chambers, S K Chambers, E I Kohorn, et al.
Gynecologic Oncology|February 13, 2001
The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinomaE P Toy, J T Chambers, B M Kacinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II studyS K Chambers, C A Davis, P E Schwartz, et al.
Gynecologic Oncology|January 16, 1999
Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survivalP E Schwartz, T J Rutherford, J T Chambers, et al.
Obstetrics and Gynecology|September 1, 1989
CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinomaP C Tseng, H E Sprance, M L Carcangiu, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|May 1, 1994
Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocolS K Chambers, L Lamb, E I Kohorn, et al.
Obstetrics and Gynecology|February 1, 1985
Immediate versus delayed hysterectomy for endometrial carcinoma: surgical morbidity and hospital stayJ T Chambers, D S Kapp, R Lawrence, et al.
Obstetrics and Gynecology|September 1, 1988
Evaluation of the role of second-look surgery in ovarian cancerS K Chambers, J T Chambers, E I Kohorn, et al.
American Journal of Clinical Pathology|September 1, 1990
Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlationsM L Carcangiu, J T Chambers, I M Voynick, et al.
Obstetrics and Gynecology|January 1, 1987
Uterine papillary serous carcinomaJ T Chambers, M Merino, E I Kohorn, et al.
Gynecologic Oncology|March 1, 1996
Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamideJ T Chambers, S K Chambers, E I Kohorn, et al.
Gynecologic Oncology|February 13, 2001
The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinomaE P Toy, J T Chambers, B M Kacinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II studyS K Chambers, C A Davis, P E Schwartz, et al.
Gynecologic Oncology|January 16, 1999
Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survivalP E Schwartz, T J Rutherford, J T Chambers, et al.
Obstetrics and Gynecology|September 1, 1989
CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinomaP C Tseng, H E Sprance, M L Carcangiu, et al.
Pageof 8